Skip to main content
Premium Trial:

Request an Annual Quote

NIA, UK Partner to Fund Studies of the Molecular Basis of Aging

NEW YORK (GenomeWeb News) – The National Institute on Aging and the United Kingdom’s Biotechnology and Biological Sciences Research Council will partner through a fund-matching program to support collaborative research into the molecular, cellular, and physiological underpinnings of aging and the functional decline and disorders that accompany it.
 
NIA will spend a total of $1 million in 2009 to fund between five and six awards. Each investigator may seek up to $200,000 per year over a three year term from NIA. Matching funds from the BBSRC will be available to support the UK component of the studies.
 
These collaborative projects in the US and UK will focus on advancing knowledge about the basic biology of aging. BBSRC and NIA have identified several aspects of aging that are priority areas where collaboration between investigators in the UK and US could help advance our knowledge of these mechanisms.
 
These studies could include research into the epigenetics and epigenomics of aging, the molecular and genetic basis of aging and longevity, integrative systems biology research, adult stem cell biology, the biological basis of frailty, and other areas.
 
More information about this funding opportunity may be found here.
 
 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.